Elbasvir-grazoprevir drug combination
Showing 1 - 25 of >10,000
Chronic Hepatitis c, Liver Transplant Infection, Kidney Transplant Infection Trial in Taichung (grazoprevir 100 mg/ elbasvir 50
Terminated
- Chronic Hepatitis c
- +2 more
- grazoprevir 100 mg/ elbasvir 50 mg, Zepatier®
-
Taichung, Taiwan
- +1 more
Mar 14, 2021
Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets)
Completed
- Chronic Hepatitis C
- Grazoprevir 100 mg/Elbasvir 50 mg fixed-dose combination tablets
- (no location specified)
Jan 15, 2021
Zepatier in Patients With Substance Use
Active, not recruiting
- Hepatitis C
- +3 more
- Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jun 28, 2022
Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)
Completed
- Hepatitis C, Chronic
- Elbasvir, Grazoprevir 50-100Mg Oral Tablet
-
Riyadh, Saudi ArabiaKing Fahad Medical City
Nov 18, 2020
Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)
Completed
- Chronic HCV Infection
- Elbasvir/Grazoprevir Fixed Dose Combination
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Sep 9, 2020
Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)
Completed
- Hepatitis C Infection
- Grazoprevir + Elbasvir
- Ribavirin
- (no location specified)
Jan 15, 2021
HCV Infection Trial in Worldwide (EBR/GZR FDC Tablet, Placebo, Grazoprevir Oral Granules)
Completed
- HCV Infection
- EBR/GZR FDC Tablet
- +3 more
-
San Francisco, California
- +14 more
Jun 8, 2021
Cardiovascular Diseases, Hepatitis C, Hiv Trial in Washington, Baltimore (Elbasvir / Grazoprevir Oral Tablet [Zepatier], Cardiac
Active, not recruiting
- Cardiovascular Diseases
- +2 more
- Elbasvir / Grazoprevir Oral Tablet [Zepatier]
- Cardiac MRI
-
Washington, District of Columbia
- +1 more
Feb 1, 2023
Hepatitis C, Hemodialysis, Nosocomial Infection Trial in Philadelphia (Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier])
Completed
- Hepatitis C
- +2 more
- Elbasvir 50 MG / Grazoprevir 100 MG [Zepatier]
-
Philadelphia, PennsylvaniaPenn Presbyterian Medical Center
Nov 17, 2021
Renal Failure Trial in Boston (elbasvir (50mg) / grazoprevir (100mg) (fixed dose combination))
Completed
- Renal Failure
- elbasvir (50mg) / grazoprevir (100mg) (fixed dose combination)
-
Boston, MassachusettsMassachusetts General Hospital
May 19, 2020
Hepatitis C Trial in Darlinghurst, Kingswood, Newcastle (Grazoprevir/elbasvir)
Terminated
- Hepatitis C
-
Darlinghurst, New South Wales, Australia
- +4 more
Feb 21, 2020
Hepatitis C, Renal Insufficiency, Chronic, Disorder of Transplanted Kidney Trial in Baltimore (Post-transplant Grazoprevir and
Active, not recruiting
- Hepatitis C
- +2 more
- Post-transplant Grazoprevir and Elbasvir
-
Baltimore, MarylandUniversity of Maryland Medical Center
Oct 5, 2021
Hepatitis C, Medication Adherence Trial in Bronx (AiCure, AiCure with gamification)
Completed
- Hepatitis C
- Medication Adherence
- AiCure
- AiCure with gamification
-
Bronx, New YorkAlbert Einstein College of Medicine Division of Substance Abuse
Aug 19, 2021
Hepatitis C, Deglutition Disorders Trial in Nijmegen (Zepatier whole tablet, Zepatier crushed tablet)
Completed
- Hepatitis C
- Deglutition Disorders
- Zepatier whole tablet
- Zepatier crushed tablet
-
Nijmegen, NetherlandsRTCCS Radboudumc
Oct 16, 2020
Chronic Hepatitis C Trial (Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A), Placebo to Grazoprevir 100 mg/Elbasvir 50 mg
Completed
- Chronic Hepatitis C
- Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet (MK-5172A)
- Placebo to Grazoprevir 100 mg/Elbasvir 50 mg FDC tablet
- (no location specified)
Nov 11, 2019
Hepatocellular Carcinoma, Hepatoma, Liver Cell Carcinoma Trial (Elbasvir / Grazoprevir Oral Tablet)
Withdrawn
- Hepatocellular Carcinoma
- +3 more
- Elbasvir / Grazoprevir Oral Tablet
- (no location specified)
Sep 6, 2020
Hepatitis C Virus Infection, Response to Therapy of Trial in Cairo (Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER])
Withdrawn
- Hepatitis C Virus Infection, Response to Therapy of
- Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
-
Cairo, Almanial, EgyptKasr Alainy Hospital
Apr 16, 2020
Hepatitis C, Substance Use Disorders, Substance Abuse, Intravenous Trial in Portland (elbasvir-grazoprevir (50 mg/100 mg))
Completed
- Hepatitis C
- +2 more
- elbasvir-grazoprevir (50 mg/100 mg)
-
Portland, Oregon
- +1 more
Oct 19, 2020
Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))
Recruiting
- Hepatitis C
- Sofosbuvir 400mg [Sovaldi]
- Glecaprevir/pibrentasvir (300mg/120mg)
-
Darlinghurst, New South Wales, Australia
- +2 more
Mar 28, 2022
Chronic Hepatitis C Trial in United States (SOF/LDV (sofosbuvir/ledipasvir), PrOD (ombitasvir/paritaprevir/ritonavir with
Completed
- Chronic Hepatitis C
- SOF/LDV (sofosbuvir/ledipasvir)
- +3 more
-
Little Rock, Arkansas
- +37 more
Dec 1, 2021
Compensated Cirrhosis Trial in Bangkok (Grazaoprevir/Elbasavir, Grazaoprevir/Elbasavir/RBV)
Unknown status
- Compensated Cirrhosis
-
Bangkok, Thailand
- +1 more
Feb 11, 2020